Haleon plc

NYSE:HLN

Drug Manufacturers - Specialty & Generic

Healthcare
$9.08 +0.96%

+$0.08 today

Market cap
$39.85B
Beta
0.25
P/E (TTM)
29.2
EPS (TTM)
$0.11
Dividend yield
2.13%
52W Low $8.65High $11.28

Volume 19.46M

Average 8.79M

HLN Common Stock Repurchased

Cash spent buying back the company's own shares.

Haleon plcNYSE: HLN

Common Stock Repurchased · Q4 FY2025 · quarter ended Dec 2025

Common stock repurchased turns negative

Q4 FY2025 common stock repurchased was -£291.97M, compared with £0 a year earlier.

Context

  • Common stock repurchased amounted to 5.8% of revenue in FY2025, up 4.7 pp from a year earlier.
  • Common stock repurchased increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
-£291.97M— QoQ
Last fiscal yearDec 2025
-£639.67M+428.7% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+428.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

GBP · from the cash flow

Latest · FY2025
(639.67M) GBP
Year-over-year change
-428.7%

Common Stock Repurchased vs competitors

How HLN compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +428.7% is the highest of 5, against a peer median of +19.9%.
  • Common stock repurchased amounts to 5.8% of revenue for HLN, versus a peer median of 3.3%.
HLN Competitors
Common Stock Repurchased for HLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CLColgate-Palmolive CompanyLTM Sep 2026$1.33B USD+5.9%-2.6%6.3%
GSKGSK plcLTM Jun 2026£1.08B GBP+34.0%—3.3%
HLNHaleon plcFY2025£639.67M GBP+428.7%—5.8%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$337.1M USD-43.8%—5.4%
KVUEKenvue Inc.LTM Sep 2026$0 USD+100.0%—0.0%
PRGOPerrigo Company plcLTM Jun 2026$0 USD——0.0%
Peer median (excluding HLN) —+19.9%-2.6%3.3%

Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

GBP
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.39B1.12B1.3B1.44B1.63B
Depreciation & Amortization268M287M309M324M352.11M
Deferred Income Tax197M62M000
Stock-Based Compensation59M78M88M102M0
Change in Working Capital(152M)181M(107M)48M250.39M
Accounts Receivables14M(85M)38M(312M)(63.58M)
Inventory(17M)(292M)(131M)216M130.09M
Accounts Payables41M387M112M0122.26M
Other Working Capital(190M)171M(126M)144M61.62M
Other Non-Cash Items(406M)336M506.04M385M52.82M
Operating Cash Flow1.36B2.06B2.1B2.3B2.29B
Capital Expenditures(298M)(328M)(336M)(250M)(314.94M)
Acquisitions (Net)112M9.21B(71M)0(157.47M)
Purchases of Investments(112M)(9.21B)00(5.87M)
Sales of Investments100M700M000
Other Investing Activities165M(9.16B)171M778M0
Investing Cash Flow(33M)(8.78B)(134M)528M(567.29M)
Debt Repayment8M9.49B(553M)592M(1.28B)
Common Stock Issued00000
Common Stock Repurchased00(38M)(121M)(639.67M)
Dividends Paid(1.15B)(2.68B)(388M)(570M)(598.59M)
Other Financing Activities(96M)107M(589M)(1.44B)(39.12M)
Financing Cash Flow(1.24B)6.91B(1.57B)(1.54B)(2.55B)
Effect of Forex Changes(5M)15M(15M)(79M)66.6M
Net Change in Cash82M205M383M1.21B(769.66M)
Free Cash Flow1.06B1.74B1.76B2.05B1.97B

Haleon plc

NYSE:HLN

Intrinsic Alpha fair value

Locked

Current Price

$9.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.